Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy

BACKGROUND: Interstitial inflammation is a prominent feature associated with the severity of renal injury and progressive kidney failure. We utilized an animal model of aristolochic acid (AA)-induced nephropathy (AAN) to assess patterns of infiltration and inflammation during the evolution of tubulointerstitial damage and to relate them to the development of fibrosis.

METHODS: Male Wistar rats receiving sc daily AA or vehicle were sacrificed between Days 1 and 35. Infiltrating mononuclear cells were characterized by immunohistochemistry. The kidney infiltrating T lymphocytes were phenotyped by flow cytometry. Urinary levels of Th-1/ Th-2 cytokines, of monocyte chemoattractant protein-1 and of active transforming growth factor-beta (TGF-beta) were measured. Tissue expression of phosphorylated smad 2/3 protein was used to examine the TGF-beta signalling pathway.

RESULTS: In AA rats, monocytes/macrophages and T lymphocytes predominantly infiltrated areas of necrotic proximal tubular cells. The coexpressions of ED1 and/or Ki-67/MHCII by infiltrating cells reflected monocyte/macrophage proliferation and their activation, respectively. The accumulation of cytotoxic T lymphocytes was attested by severe signs of CD8+ cell tubulitis. The CD8/E-cadherin costaining confirmed intrarenal homing of CD8+CD103+ cells. Urinary levels of proinflammatory cytokines and of active TGF-beta significantly increased at Days 10 and 35. An early and persistent nuclear overexpression of phosphorylated smad 2/3 protein was detected in tubular and interstitial compartments.

CONCLUSION: An early and massive interstitial inflammation characterized by activated monocytes/macrophages and cytotoxic CD8+CD103+ T lymphocytes is demonstrated for the first time during the progression of experimental AAN. The involvement in an interstitial fibrosis onset of active TGF-beta is highly suggested, at least via the psmad 2/3 intracellular signalling pathway.

Medienart:

E-Artikel

Erscheinungsjahr:

2008

Erschienen:

2008

Enthalten in:

Zur Gesamtaufnahme - volume:23

Enthalten in:

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association - 23(2008), 8 vom: 08. Aug., Seite 2480-91

Sprache:

Englisch

Beteiligte Personen:

Pozdzik, Agnieszka A [VerfasserIn]
Salmon, Isabelle J [VerfasserIn]
Husson, Cécile P [VerfasserIn]
Decaestecker, Christine [VerfasserIn]
Rogier, Edith [VerfasserIn]
Bourgeade, Marie-Françoise [VerfasserIn]
Deschodt-Lanckman, Monique M [VerfasserIn]
Vanherweghem, Jean-Louis [VerfasserIn]
Nortier, Joëlle L [VerfasserIn]

Links:

Volltext

Themen:

94218WFP5T
Aristolochic Acids
Aristolochic acid I
Journal Article
Research Support, Non-U.S. Gov't
SMAD2 protein, human
SMAD3 protein, human
Smad2 Protein
Smad3 Protein
Transforming Growth Factor beta

Anmerkungen:

Date Completed 20.02.2009

Date Revised 24.11.2016

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1093/ndt/gfn140

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM178670227